Adaptive Biotechnologies (ADPT) Net Income towards Common Stockholders Growth (3y) (2021 - 2026)

Adaptive Biotechnologies (ADPT) Net Income towards Common Stockholders Growth (3y) (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income Growth (3y) (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	8.89%
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-7.69%
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	15.47%
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	3.93%
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	-6.41%
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	14.70%
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	42.35%
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	2.87%
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	16.51%
10	Adaptive Biotechnologies	4.23 Bn	3.89 Bn	51.39 Mn	30.27%

Download Data